“…Genotypic analyses of transplant recipients, and in some instances that of donors, may also help determine the risk of active CMV infection and invasive disease. Some single nucleotide polymorphisms (SNPs) in genes encoding pattern recognition molecules and receptors (mannose‐binding lectin, ficolin‐2, toll‐like receptors 2, 4, and 9, dendritic cell‐specific ICAM3‐grabbing non‐integrin, and chemokine receptor 5), cytokines and chemokines (interleukin‐12, interleukin‐10, interferon‐γ, interferon‐λ3 ‐IL28B‐, and monocyte chemoattractant protein 1), and immune regulatory membrane‐associated proteins (human programmed death‐1) appear to be associated with a higher risk of developing active CMV infection, CMV end‐organ disease, or both, in allogeneic stem cell and SOT transplantation settings [Loeffler et al, ; Cervera et al, , ; Kijpittayarit et al, ; Hoffmann et al, , ; Mezger et al, ; Brown et al, ; de Rooij et al, ; Mitsani et al, ; Kang et al, ; Bravo et al, ; Egli et al, ; Corrales et al, ; Fernández‐Ruiz et al, ; Manuel et al, ]. These SNPs may also have an impact on the dynamics of CMV replication within episodes of active CMV infection [Corrales et al, ].…”